Efficacy of Laflavon in Lowering Triglycerides and Raising High-Density Lipoprotein (HDL)

Femme et Homme

| Pays :
Lebanon
| Organes :
| Spécialités :

Extrait

A trial of LaFlavon in Patients with Metabolic Syndrome to Evaluate its Effectiveness in Lowering Triglycerides and Raising High-Density Lipoprotein (HDL).

Critère d'inclusion

Metabolic Disease

Liens

nct
ictrp